Information Provided By: 
Fly News Breaks for June 8, 2015
SNY, REGN, AMGN
Jun 8, 2015 | 09:25 EDT
Piper Jaffray says the FDA panel's briefing documents for Amgen's Repatha are only slightly different to the panel's review of Regeneron (REGN) and Sanofi's (SNY) Praluent which were released on Friday. Piper believes nothing in the documents will disrupt approval of either drug. It keeps an Overweight rating on Amgen.
News For AMGN;REGN;SNY From the Last 2 Days
SNY
Apr 22, 2024 | 12:15 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
SNY
Apr 22, 2024 | 11:36 EDT
